Table 2 Estimated Hazard Ratios Modeling Time to Death (with time-fixed study setting variable), Time to First Hospitalization (with time-fixed study setting variable), and Time to First Hospitalization (with time-varying study setting variable)
|
Time-Fixed: Time to Death HR (95% CI) |
Time-Fixed: Time to First Hospitalization HR (95% CI) |
Time-Varying: Time to First Hospitalization HR (95% CI) | |
|---|---|---|---|
|
Study Setting (RCT vs. Cohort Study) Non-Time-Varying |
1.28 (0.76, 2.13) |
0.72 (0.58,0.89) | N/A |
|
Study Setting (RCT vs. Cohort Study) Time-Varying | N/A | N/A |
0.42 (0.31, 0.58) |
| Sex (Male vs. Female) |
0.92 (0.59,1.45 |
1.25 (1.02,1.54) |
1.25 (1.02, 1.54) |
|
Site Type (Non-Urban vs. Urban) |
0.79 (0.49,1.26) |
1.04 (0.84,1.28) |
1.05 (0.85, 1.30 |
|
SES Score (Increasing SES Status) |
0.84 (0.70,1.01) |
0.94 (0.86,1.02) |
0.94 (0.87, 1.02) |
| Breastfeeding Strategy (Exclusively Formula Fed vs. Ever Breastfed) |
1.19 (0.65,2.18) |
1.37 (1.03,1.83) |
1.34 (1.01, 1.79) |
|
Pregnancy ARV Strategy (Reference: None) | |||
|
Pregnancy ARV Strategy (ZDV Only) |
0.86 (0.25,2.98) |
1.00 (0.56,1.77) |
1.03 (0.58, 1.83) |
|
Pregnancy ARV Strategy (3-drug ART) |
0.60 (0.18,1.99) |
0.76 (0.44,1.32) |
0.82 (0.47, 1.41) |
|
Birthweight Status (Not Low-Birthweight vs Low-Birthweight) |
0.58 (0.34,0.97) |
1.01 (0.76,1.33) |
1.00 (0.76, 1.33) |